Back
Pacific Biosciences of California Stock Predictions
Sponsored
PACB
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
38
PACB
Pacific Biosciences of California
Last Price:
1.60
Seasonality Move:
21.6%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Pacific Biosciences of California Stock Forecast
-
Is Pacific Biosciences of California Stock Undervalued?
The current Pacific Biosciences of California [PACB] share price is $1.60. The Score for PACB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - PACB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Pacific Biosciences of California Stock Go Up Next Year?
Data Unavailable
Pacific Biosciences of California Stock Rating
Data Unavailable
Pacific Biosciences of California Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
pacb.com
52-Week Data
52-Week High:
10.65
52-Week Low:
1.16
Prediction Charts
Market Cap:
436.81M
Price in USD:
1.60
Volume:
22.68M
Beta:
2.10
Technical Analysis
SMA50:
1.91
SMA100:
1.75
SMA200:
2.50
52-Wk Change:
-79.58%
Stock Predictions
-
Is Pacific Biosciences of California stock public?
Yes, Pacific Biosciences of California is a publicly traded company. -
What is the Pacific Biosciences of California stock quote today?
The Pacific Biosciences of California stock price is 1.60 USD today. -
How to buy Pacific Biosciences of California stock online?
You can buy Pacific Biosciences of California shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-29 | 1.86 | 2.07 | 2.08 | 1.81 |
Oct-30 | 2.02 | 2.17 | 2.40 | 2.02 |
Oct-31 | 2.15 | 2.17 | 2.24 | 2.07 |
Nov-1 | 2.21 | 2.44 | 2.50 | 2.18 |
Nov-4 | 2.45 | 2.52 | 2.58 | 2.34 |
Nov-5 | 2.45 | 2.55 | 2.65 | 2.41 |
Nov-6 | 2.63 | 2.65 | 2.70 | 2.38 |
Nov-7 | 2.71 | 2.45 | 2.72 | 2.38 |
Nov-8 | 2.18 | 2.30 | 2.64 | 1.82 |
Nov-11 | 2.34 | 2.46 | 2.46 | 2.17 |
Nov-12 | 2.44 | 2.20 | 2.66 | 2.18 |
Nov-13 | 2.26 | 1.98 | 2.30 | 1.98 |
Nov-14 | 2.01 | 1.86 | 2.03 | 1.85 |
Nov-15 | 1.88 | 1.60 | 1.88 | 1.56 |
Pacific Biosciences of California Earnings
Data Unavailable
Pacific Biosciences of California Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.17 per share.
* Pacific Biosciences of California stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.